SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 205.55-1.3%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Peter Singleton who wrote (20816)5/14/1998 9:27:00 PM
From: RXGOLF  Read Replies (2) of 32384
 
Hi Peter,
Thanks for the well thought out post.A couple of observations:

1.IMHO Henry never validated the accuracy of the H&Q numbers, he just quoted that this was indeed their estimate. And, I think it was indeed their estimate, and few of us, including Henry, thought this was the most accurate est.

2.Toxicity should be a concern for anyone hoping to bring a drug to market. Safety AND efficacy are of course cornerstones to a profitable product. Every drug has side effects, but the numbers you posted did alarm me also.

3.For we, the stock holders, further dilution dilutes our future earnings. I too consider this a big issue.

4. You didn't have a 4., but the pipeline and management of this company are going to make us all happy in the end in spite of all our valid concerns!!

Good Luck,
Greg
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext